The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition.
immune checkpoint inhibition
lung metastasis
melanoma
plasma membrane calcium ATPase 4
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
19 Mar 2022
19 Mar 2022
Historique:
received:
23
02
2022
revised:
16
03
2022
accepted:
17
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
9
4
2022
Statut:
epublish
Résumé
PMCA4 is a critical regulator of Ca
Identifiants
pubmed: 35328746
pii: ijms23063324
doi: 10.3390/ijms23063324
pmc: PMC8949876
pii:
doi:
Substances chimiques
Immune Checkpoint Inhibitors
0
Programmed Cell Death 1 Receptor
0
RNA, Messenger
0
Plasma Membrane Calcium-Transporting ATPases
EC 3.6.3.8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : SCHA422/17-1
Organisme : Ministry for Innovation and Technology in Hungary
ID : 2020-1.1.6-JÖVŐ-2021-00013
Organisme : Ministry for Innovation and Technology in Hungary
ID : 2020-4.1.1.-TKP2020
Organisme : Hungarian Scientific Research Fund
ID : NKFI K119223
Organisme : Hungarian Scientific Research Fund
ID : K135811
Références
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Sci Rep. 2017 Aug 21;7(1):8358
pubmed: 28827723
J Immunol. 2016 Feb 1;196(3):1387-99
pubmed: 26729804
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6092-7
pubmed: 15833814
Mol Med Rep. 2021 Feb;23(2):
pubmed: 33355366
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
N Engl J Med. 2015 Nov 12;373(20):1926-36
pubmed: 26559571
J Neurooncol. 2016 May;127(3):435-44
pubmed: 26744134
Expert Rev Anticancer Ther. 2020 Feb;20(2):137-145
pubmed: 31997676
JCO Oncol Pract. 2022 Feb 8;:OP2100686
pubmed: 35133862
Cancer Invest. 2012 May;30(4):251-7
pubmed: 22480210
J Med Internet Res. 2021 Jul 26;23(7):e27633
pubmed: 34309564
Brain Behav. 2015 Apr;5(4):e00321
pubmed: 25798335
Eur J Cardiothorac Surg. 2019 Dec 1;56(6):1104-1109
pubmed: 31321422
Clin Lab Med. 2017 Sep;37(3):449-471
pubmed: 28802495
Nat Rev Cancer. 2016 Jun;16(6):345-58
pubmed: 27125352
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
J Cell Biol. 2012 Dec 24;199(7):1145-58
pubmed: 23266958
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Biochim Biophys Acta Mol Cell Res. 2020 Dec;1867(12):118833
pubmed: 32860837
Cancers (Basel). 2021 Mar 17;13(6):
pubmed: 33802790
Physiol Rev. 2017 Jul 1;97(3):1089-1125
pubmed: 28566538
J Physiol. 2002 Jun 15;541(Pt 3):877-94
pubmed: 12068047
Cancers (Basel). 2020 Jan 16;12(1):
pubmed: 31963119
Clin Cancer Res. 2005 Oct 15;11(20):7234-42
pubmed: 16243793
Nat Med. 2019 Dec;25(12):1916-1927
pubmed: 31792460
N Engl J Med. 2015 Jan 22;372(4):320-30
pubmed: 25399552
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
N Engl J Med. 2011 Jun 30;364(26):2507-16
pubmed: 21639808
Int J Cancer. 2017 Jun 15;140(12):2758-2770
pubmed: 27813079
Cell Calcium. 2014 Feb;55(2):78-92
pubmed: 24439526
J Natl Cancer Inst. 2013 Jun 19;105(12):917-9
pubmed: 23690527
N Engl J Med. 2015 Jan 1;372(1):30-9
pubmed: 25399551
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Cancers (Basel). 2020 Jul 07;12(7):
pubmed: 32645881
Cells. 2020 May 13;9(5):
pubmed: 32414111
Front Oncol. 2021 Feb 04;10:626129
pubmed: 33614507
Lancet Oncol. 2018 Jun;19(6):737-746
pubmed: 29778737
BMC Cancer. 2018 Oct 23;18(1):1029
pubmed: 30352569
Biochim Biophys Acta. 2016 Jun;1863(6 Pt B):1351-63
pubmed: 26707182
Front Oncol. 2017 May 24;7:95
pubmed: 28596940
N Engl J Med. 2005 Nov 17;353(20):2135-47
pubmed: 16291983
Nature. 2020 Dec;588(7837):331-336
pubmed: 33299191
Br J Ophthalmol. 2017 Jan;101(1):38-44
pubmed: 27574175
Acta Pharm Sin B. 2017 Jan;7(1):3-17
pubmed: 28119804
Neuron. 2017 Nov 15;96(4):827-838.e9
pubmed: 29056295
Clin Transl Med. 2021 Jul;11(7):e451
pubmed: 34323402